| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CNTB
Connect Biopharma Holdings
|
Jun 17, 2026 | BUY |
Strong Buy
+226.3% avg upside
11 analysts
|
$6.00
200.03% Upside
|
· |
|
TVTX
Travere Therapeutics
|
Jun 02, 2026 | BUY |
Strong Buy
-16.0% avg upside
22 analysts
|
$56.00
1.44% Upside
|
+21.1% |
|
KYMR
Kymera Therapeutics
|
Jun 01, 2026 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$106.00
17.22% Upside
|
+14.6% |
|
APGE
Apogee Therapeutics
|
May 28, 2026 | BUY |
Strong Buy
+28.5% avg upside
19 analysts
|
$130.00
43.75% Upside
|
+16.1% |
|
CORT
Corcept Therapeutics
|
May 28, 2026 | BUY |
Strong Buy
-45.5% avg upside
15 analysts
|
$135.00
69.02% Upside
|
+19.6% |
|
RANI
Rani Therapeutics Holdings
|
May 20, 2026 | BUY |
Strong Buy
+1114.2% avg upside
10 analysts
|
$5.00
539.02% Upside
|
· |
|
TSE:CRDL
Cardiol Therapeutics
|
May 19, 2026 | BUY |
Strong Buy
+634.8% avg upside
6 analysts
|
$11.33
652.80% Upside
|
· |
|
VERU
Veru
|
May 14, 2026 | BUY |
Strong Buy
+568.5% avg upside
10 analysts
|
$25.00
747.41% Upside
|
+13.4% |
|
SGMT
Sagimet Biosciences, Inc. Class A
|
May 12, 2026 | BUY |
Strong Buy
+317.2% avg upside
15 analysts
|
$49.00
633.57% Upside
|
-9.8% |
|
PLRX
Pliant Therapeutics
|
May 12, 2026 | HOLD |
Buy
+1821.1% avg upside
21 analysts
|
$3.00
158.55% Upside
|
+4.2% |
|
GPCR
Structure Therapeutics, Inc. Sponsored ADR
|
May 08, 2026 | BUY |
Strong Buy
+132.5% avg upside
17 analysts
|
$101.00
126.98% Upside
|
-6.5% |
|
CLDX
Celldex
|
May 08, 2026 | BUY |
Strong Buy
+20.6% avg upside
28 analysts
|
$62.00
91.26% Upside
|
-4.5% |
|
MDGL
Madrigal Pharmaceuticals
|
May 07, 2026 | BUY |
Strong Buy
-5.8% avg upside
31 analysts
|
$578.00
14.26% Upside
|
-5.4% |
|
VKTX
Viking Therapeutics
|
May 04, 2026 | BUY |
Strong Buy
+141.1% avg upside
30 analysts
|
$107.00
252.11% Upside
|
-6.6% |
|
KNSA
Kiniksa Pharmaceuticals
|
Apr 29, 2026 | BUY |
Strong Buy
-0.2% avg upside
11 analysts
|
$64.00
16.21% Upside
|
-1.2% |
|
IVA
Inventiva
|
Apr 02, 2026 | BUY |
Strong Buy
+350.1% avg upside
16 analysts
|
$20.00
460.30% Upside
|
-33.8% |
|
RZLT
Rezolute
|
Oct 02, 2024 | BUY |
Strong Buy
+122.8% avg upside
13 analysts
|
$9.00
79.21% Upside
|
+95.1% |
|
ORMP
Oramed Pharm
|
May 17, 2023 | HOLD |
Strong Buy
+394.8% avg upside
7 analysts
|
$2.00
48.41% Downside
|
-36.6% |
|
GLMD
Galmed Pharmaceuticals
|
Aug 08, 2022 | HOLD |
Buy
+4113.3% avg upside
13 analysts
|
$15.00
2486.26% Upside
|
-86.5% |
|
OBSEF
ObsEva
|
Jul 29, 2022 | HOLD |
Buy
+10799900.0% avg upside
8 analysts
|
$1.00
999900.03% Upside
|
· |
|
XGN
Exagen
|
May 18, 2021 | BUY |
Strong Buy
+159.4% avg upside
10 analysts
|
$25.00
450.61% Upside
|
-68.0% |
|
CPRX
Catalyst Pharma
|
Aug 09, 2019 | BUY |
Strong Buy
-17.0% avg upside
15 analysts
|
$11.00
64.91% Downside
|
-19.5% |
|
IFRX
InflaRx
|
Jun 05, 2019 | HOLD |
Buy
+390.4% avg upside
11 analysts
|
$5.00
176.29% Upside
|
+144.8% |
|
WVE
Wave Life Sciences
|
May 20, 2019 | BUY |
Strong Buy
+260.5% avg upside
28 analysts
|
$39.00
533.20% Upside
|
-55.2% |
|
SRPT
Sarepta Therapeutics
|
Feb 27, 2019 | BUY |
Buy
+244.5% avg upside
49 analysts
|
$176.00
903.94% Upside
|
-29.0% |
|
QURE
uniQure
|
Feb 26, 2019 | BUY |
Strong Buy
+16.1% avg upside
29 analysts
|
$64.00
38.25% Upside
|
+0.0% |
|
BMRN
BioMarin Pharmaceutical
|
Feb 25, 2019 | BUY |
Strong Buy
+72.8% avg upside
52 analysts
|
$117.00
113.95% Upside
|
-0.4% |
|
RARE
Ultragenyx Pharmaceutical
|
Jan 23, 2019 | BUY |
Strong Buy
+142.1% avg upside
36 analysts
|
$71.00
158.75% Upside
|
+16.2% |
|
ANAB
AnaptysBio
|
Sep 24, 2018 | BUY |
Strong Buy
+26.1% avg upside
26 analysts
|
$156.00
171.30% Upside
|
-62.3% |
|
ARGX
Argenx Se
|
Sep 17, 2018 | BUY |
Strong Buy
-15.8% avg upside
46 analysts
|
$132.00
84.91% Downside
|
+37.5% |
|
SMMT
Summit Therapeutics
|
Jun 27, 2018 | HOLD |
Strong Buy
+112.6% avg upside
27 analysts
|
$4.00
70.95% Downside
|
-48.6% |
|
ELOX
Eloxx Pharmaceuticals
|
Jun 25, 2018 | BUY |
Strong Buy
+153.9% avg upside
8 analysts
|
$26.00
85.99% Upside
|
-49.2% |
|
ABEO
Abeona Therapeutics
|
May 16, 2018 | BUY |
Strong Buy
+195.8% avg upside
17 analysts
|
$23.00
298.70% Upside
|
-64.5% |
|
NBRVF
Nabriva Therapeutics
|
Sep 18, 2017 | BUY |
Strong Buy
+13374900.0% avg upside
9 analysts
|
$24.00
23999899.91% Upside
|
· |
|
ANTH
Anthera Pharmaceuticals
|
May 16, 2017 | HOLD |
Buy
+472857042.9% avg upside
9 analysts
|
$2.00
199999899.97% Upside
|
· |
|
LRMR
Larimar Therapeutics
|
May 05, 2017 | HOLD |
Strong Buy
+409.3% avg upside
21 analysts
|
$6.00
64.83% Upside
|
+43.6% |
|
IMUX
Immunic
|
Mar 07, 2017 | HOLD |
Strong Buy
+166.0% avg upside
21 analysts
|
$9.00
36.68% Downside
|
+26.4% |
|
IRWD
Ironwood Pharma
|
Sep 04, 2014 | HOLD |
Buy
+235.6% avg upside
23 analysts
|
$10.50
196.67% Upside
|
-10.8% |
|
SGMO
Sangamo Therapeutics
|
Jun 17, 2013 | BUY |
Buy
+5844.2% avg upside
16 analysts
|
— | +109.4% |
|
DCTH
Delcath Systems
|
May 03, 2013 | SELL |
Strong Buy
+90.3% avg upside
11 analysts
|
— | · |
|
ACAD
ACADIA Pharmaceuticals
|
Jan 28, 2013 | BUY |
Strong Buy
+65.9% avg upside
42 analysts
|
— | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.